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BACKGROUND: Atrial fibrillation (AF) is common in ST-segment elevation
myocardial infarction (STEMI), but its influence on prognosis remains controversial.
AIM: We examined the 1-year prognostic value of AF in STEMI, distinguishing
patients with prior AF from patients with de novo AF.
METHODS: Between January 2004 and December 2015, 3173 STEMI patients were
enrolled in the RIMA registry (Registre des Infarctus en Maine Anjou). They were
divided into 3 groups: (1) AF-free patients; (2) patients with known prior AF; and (3)
patients with de novo AF during hospitalization (including admission). We defined 3
primary outcomes at 1-year post-discharge: cardiovascular mortality, readmission
for heart failure (HF), and stroke. Temporal onset of de novo AF was also studied.
RESULTS: A total 158 patients (5%) had prior AF, and 278 (8.8%) presented de novo
AF. Prior AF patients were significantly older [81 (73;86) years] with more
comorbidities, but de novo AF patients presented with a greater creatine kinase
peak and lower left ventricular ejection fraction [LVEF=44 (35;50)% for de novo AF
vs 50 (40;55)% for prior AF, p<0.001]. At 1-year follow-up, cardiovascular mortality
was higher in cases of AF (13.5% for prior AF vs 9.2% for de novo AF, compared
with 2.4% for AF-free patients, p<0.001). After adjustments, only de novo AF was
correlated with cardiovascular mortality (hazard ratio 2.49; 95% CI 1.32-4.67;
p=0.004), but both types of AF were correlated with readmission for HF. There was
no significant difference in respect of stroke between prior AF, de novo AF, and AF-
free (2.2%, 0.5%, and 0.8%, respectively, p=0.327). Finally, outcomes did not differ
between AF occurring <24h after admission (n=127) and de novo AF occurring
within ≥24h (n=151).
CONCLUSION: De novo AF was independently associated with 1-year
cardiovascular mortality. It should not be considered as an intercurrent event of
STEMI, but rather as a strong prognostic marker.
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